Danimer Scientific's Days Sales Outstanding for the
three
months ended in Mar. 2024 was 122.54.
Danimer Scientific's Days Inventory for the
three
months ended in Mar. 2024 was 141.44.
Danimer Scientific's Days Payable for the
three
months ended in Mar. 2024 was 25.32.
Therefore, Danimer Scientific's Cash Conversion Cycle (CCC) for the
three
months ended in Mar. 2024 was 238.66.
Danimer Scientific Cash Conversion Cycle Historical Data
The historical data trend for Danimer Scientific's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Danimer Scientific's Cash Conversion Cycle
For the Specialty Chemicals subindustry, Danimer Scientific's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Danimer Scientific's Cash Conversion Cycle Distribution in the Chemicals Industry
For the Chemicals industry and Basic Materials sector, Danimer Scientific's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Danimer Scientific's Cash Conversion Cycle falls into.
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
Danimer Scientific's Cash Conversion Cycle for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Danimer Scientific Cash Conversion Cycle Related Terms
Thank you for viewing the detailed overview of Danimer Scientific's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.
Danimer Scientific (Danimer Scientific) Business Description
Danimer Scientific Inc creates more sustainable, more natural ways to make plastic products sold under the proprietary Nodax brand name. The company's renewable and sustainable biopolymers have helped create plastic products that are 100% biodegradable and compostable. Danimer Scientific's products return to nature instead of polluting lands and waters. Its technology can be found in a vast array of plastic end-use products that people use every day. Applications for its biopolymers include additives, aqueous coatings, fibers, filaments, films, and injection-molded articles, among others. The company holds more than 470 patents and pending patent applications in nearly 20 countries for a range of manufacturing processes and biopolymer formulations.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DNMR has been successfully added to your 